Spray-dried dispersions (SDDs) are a key technology for enhancing bioavailability of poorly water-soluble compounds. SDD formulations enable increased intestinal absorption through two primary mechanisms: (1) increasing concentration of solvated drug leading to a higher driving force for passive diffusion through the intestinal epithelium, and (2) formation of colloidal species leading to increased rates of diffusion through the unstirred water layer and a rapid resupply of solvated drug at the surface of epithelial cells. While the former is achieved through the amorphous form, the latter is dependent on the formation and nature of colloidal species that are characteristic of SDD formulations.
Our previous work has shown distinct differences in polymer speciation in a given biorelevant media as a result of concentration and polymer chemistry. The goal of the current study is to evaluate how molecular weight and flexibility influences the partitioning of drug molecules into the polymer colloids.
Learning Objectives:
- Understand the concept of speciation in amorphous solid dispersions
- Understand difference between polymer colloids formed from different polymers used in amorphous dispersions
- Understand how molecular properties influence the partitioning of drug molecules into colloids
Wesley Tatum is a Principal Engineer in the Process and Product Development department at Serán. He leads a team of scientists and engineers in characterizing new API and identifying shortcomings for bioavailability. He and his team then screen and select drug product intermediates that address those shortcomings and screen and scale up drug product formulations. During his time at Serán, his work and research has focused on understanding how polymers, excipients, and physiological factors influence speciation, bioavailability, and absorption of drug substances and amorphous solid dispersions.
Wesley holds undergraduate degrees in Physics and Physical Chemistry from Whitworth University and a Ph.D. in Materials Science and Engineering from the University of Washington.
Serán Bioscience is a science-based CDMO that specializes in a variety of drug delivery and formulation approaches suited to optimizing bioavailability. Our experienced formulation team will work with you to identify an appropriate technology and formulation strategy to meet your program’s unique needs. We take a comprehensive approach to formulation design that considers the physiochemical properties of the API, the target product profile, and your program’s objectives and constraints to develop scalable formulations using efficient and material-sparing approaches.
Delivering you the simplest approach to meet your program's needs.
When I think of Solubility Problems, I think of Serán.
Consultant
Consultant, Multiple ClientsMake a batch on time. Reliable CDMO, quality product within the timelines.
Large Pharma
Large PharmaCustomers come for the flexibility and stay for the dedication.
Small Biotech
Small BiotechI’ve been impressed with Serán. One of the things we really look for is flexibility. They are a good combination of flexibility and technical competence.
Medium Size Pharma
Medium Size PharmaThe scientists we met at Serán were top notch.
Large Pharma
Large Pharma©2025 Serán Bioscience, LLC. All rights reserved. Privacy Policy